Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

102 Press Releases
DateTitleCompany
24 Jul 14 BioAlliance Pharma: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen BioAlliance Pharma,
Published by
Business Wire
23 Jul 14 The cross-border merger of BioAlliance Pharma and Topotarget is legally effective as of 22 July 2014 BioAlliance Pharma SA,
Published by
Business Wire
21 Jul 14 BioAlliance Pharma Announces the Launch of Sitavig® in the United States by Its Partner Innocutis BioAlliance Pharma SA,
Published by
Business Wire
18 Jul 14 BioAlliance Pharma Strengthens Its Financial Resources with the Support of Its Top Shareholder BioAlliance Pharma SA,
Published by
Business Wire
03 Jul 14 BioAlliance Pharma: FDA approval of Beleodaq™ (belinostat) Bioalliance Pharma,
Published by
Business Wire
30 Jun 14 Bioalliance Pharma and Topotarget Shareholders Approve Proposed Cross-Border Merger to Create Onxeo Bioalliance Pharma,
Published by
Business Wire
10 Jun 14 BioAlliance Pharma Strengthens Livatag® pAtent Protection in Japan Until 2032 BioAlliance Pharma,
Published by
Business Wire
19 May 14 BioAlliance Pharma SA: Livatag® Receives Fast Track Designation From the FDA for the Treatment of Primary Liver Cancer BioAlliance Pharma SA,
Published by
Business Wire
30 Apr 14 BioAlliance Pharma SA: Quarterly information as of March 31, 2014 BioAlliance Pharma SA,
Published by
Business Wire
29 Apr 14 BioAlliance Pharma Publishes Its First Shareholder Newsletter BioAlliance Pharma SA,
Published by
Business Wire
14 Apr 14 BioAlliance Pharma Announces a New Positive DSMB Recommendation to Continue Its Phase III Clinical Trial with Livatag® in Primary Liver Cancer BioAlliance Pharma SA,
Published by
Business Wire
02 Apr 14 BioAlliance Pharma signs a new licensing agreement with Daewoong Pharmaceutical Co., Ltd. for Sitavig®’s commercialization in South Korea BioAlliance Pharma SA,
Published by
Business Wire
01 Apr 14 BioAlliance Pharma provides an update on its partnerships for Loramyc®/Oravig® BioAlliance Pharma SA,
Published by
Business Wire
31 Mar 14 BioAlliance Pharma Collaborates with Penn Pharma on the Industrial Development of Validive® BioAlliance Pharma,
Published by
Business Wire
18 Feb 14 BioAlliance Pharma SA: Strengthening and extension of the industrial protection of Livatag® until 2031 BioAlliance Pharma SA,
Published by
Business Wire
04 Feb 14 BioAlliance Pharma’s Partner, Sosei, Announces a Partnership With FUJIFILM Pharma for Commercialization Rights for Loramyc® in Japan BioAlliance Pharma,
Published by
Business Wire
04 Dec 13 BioAlliance Pharma: Approval to start ReLive (Livatag®) Phase III Clinical Trial in Primary Liver Cancer in the U.S. and Germany BioAlliance Pharma SA,
Published by
Business Wire
14 Nov 13 BioAlliance Pharma : Quarterly information as of September 30, 2013 BioAlliance Pharma SA,
Published by
Business Wire
14 Nov 13 BioAlliance Pharma Strengthens Sitavig Patent Protection with New U.S. and South Korean issued Patents BioAlliance Pharma,
Published by
Business Wire
22 Oct 13 BioAlliance Pharma launches its new website BioAlliance Pharma SA,
Published by
Business Wire
30 Sep 13 BioAlliance Pharma : First Meeting of the International Advisory Board on Oral Mucositis and Development of Validive® BioAlliance Pharma,
Published by
Business Wire
10 Jul 13 BioAlliance Pharma Expands and Strengthens Its Industrial Property Assets with Two Patent Grants BioAlliance Pharma SA,
Published by
Business Wire
03 Jul 13 BioAlliance Pharma Receives €4.3 Million in Funding from bpifrance (ex OSEO) To Accelerate the Industrial Development of Livatag(R) BioAlliance Pharma SA,
Published by
Business Wire
27 Jun 13 BioAlliance Pharma Announces Shareholders’ Meeting and Appointment of Russell Greig and Danièle Guyot-Caparros as Independant Board Members BioAlliance Pharma,
Published by
Business Wire
10 Jun 13 BioAlliance Pharma Announces the Initiation of the Phase II Clinical Trial with Validive® in the United States BioAlliance Pharma SA,
Published by
Business Wire
27 May 13 BioAlliance Pharma presents results on Sitavig® at the 10th EADV symposium BioAlliance Pharma SA,
Published by
Business Wire
24 May 13 BioAlliance Pharma announces DSMB second positive recommendation to continue its Phase III clinical trial with Livatag® in primary liver cancer BioAlliance Pharma SA,
Published by
Business Wire
15 Apr 13 BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US For the Treatment of Herpes Labialis BioAlliance Pharma,
Published by
Business Wire
12 Mar 13 BioAlliance Pharma Pursues the Development Plan of Its Loramyc® in Japan Through Its Partner Sosei BioAlliance Pharma,
Published by
Business Wire
28 Feb 13 BioAlliance Pharma Signs a Collaborative Agreement with One of the Worldwide Leaders in Vaccines for a Vaccine Application of Its Patented Lauriad® Mucoadhesive Technology BioAlliance Pharma SA,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.